Moderate-to-Vigorous Exercise Lowers Preterm Birth Risk With Gestational Diabetes
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 23, 2024 -- Moderate- to vigorous-intensity physical activity (MVPA) during pregnancy is inversely associated with preterm birth in women with gestational diabetes (GD), according to a study published online Dec. 19 in JAMA Network Open.
Wanglong Gou, Ph.D., from Westlake Laboratory of Life Sciences and Biomedicine in China, and colleagues examined the association of accelerometer-derived physical activity metrics and patterns with preterm birth among women with GD. The analysis included 1,427 women with GD with wearable accelerometer-derived physical activity data.
The researchers found an inverse relationship between an increase in MVPA and the fraction of physical activity energy expenditure derived from MVPA with preterm birth (odds ratio per 30 minutes, 0.64 and 0.69, respectively). There was a progressive decrease in the odds of preterm birth with increasing duration of MVPA per day, which reached a plateau at 74 minutes per day. The benefit was similar whether active MVPA (≥30 minutes per day) was concentrated into a few days or followed a more regular pattern.
"These findings provide key evidence for the health benefits of MVPA during pregnancy and lay the foundation for establishing physical activity guidelines for pregnant women with GD," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Endocrine Society, July 12-15
The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.